Man Group
RVMD icon

Man Group’s Revolution Medicines RVMD Stock Holding History

Man Group’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.5M Sell
173,439
-101,831
-37% -$14.9M 0.05% 365
2026
Q1 		$26.8M Buy
275,270
+177,765
+182% +$18M 0.05% 390
2025
Q4 		$7.77M Buy
97,505
+91,511
+1,527% +$6M 0.01% 898
2025
Q3 		$280K Sell
5,994
-18,179
-75% -$712K ﹤0.01% 2028
2025
Q2 		$889K Sell
24,173
-49,685
-67% -$1.91M ﹤0.01% 1660
2025
Q1 		$2.61M Sell
73,858
-247,815
-77% -$10.1M 0.01% 1255
2024
Q4 		$14.1M Buy
321,673
+65,567
+26% +$3.31M 0.04% 590
2024
Q3 		$11.6M Sell
256,106
-26,640
-9% -$1.16M 0.03% 662
2024
Q2 		$11M Buy
282,746
+253,449
+865% +$9.47M 0.03% 668
2024
Q1 		$944K Buy
+29,297
New +$868K ﹤0.01% 1563

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Man Group's RVMD Position: Q2 2026 in Review

Man Group reduced its Revolution Medicines (RVMD) stake by 37% in Q2 2026, selling an estimated $14.9M and leaving 173,439 shares worth $32.5M. The position accounts for 0.05% of the portfolio, ranked #365.

Man Group first reported a position in RVMD in Q1 2024 and has held it in 10 quarters since. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Man Group held 173,439 shares of Revolution Medicines worth $32.5M as of Q2 2026.
  • Man Group sold 101,831 Revolution Medicines shares in Q2 2026, an estimated $14.9M.
  • Revolution Medicines made up 0.05% of Man Group's portfolio in Q2 2026, its #365 holding.
  • Man Group first reported a position in Revolution Medicines in Q1 2024 and has held it in 10 quarters since.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.